COPY-NUMBER SIGNATURES AND MUTATIONAL PROCESSES IN HIGH GRADE SEROUS OVARIAN CARCINOMA

被引：0

作者：

Macintyre, Geoff ^{[1
]}

Goranova, Teodora E. ^{[1
]}

De Silva, Dilrini ^{[1
]}

Ennis, Darren ^{[2
]}

Piskorz, Anna M. ^{[1
]}

Eldridge, Matthew ^{[1
]}

Sie, Daoud ^{[3
]}

Lewsley, Liz-Anne ^{[4
]}

Hanif, Aishah ^{[4
]}

Wilson, Cheryl ^{[4
]}

Dowson, Suzanne ^{[2
]}

Glasspool, Rosalind M. ^{[5
]}

Lockley, Michelle ^{[6
,7
]}

Brockbank, Elly ^{[8
]}

Montes, Ana ^{[9
]}

Walther, Axel ^{[10
]}

Sundar, Sudha ^{[11
]}

Edmondson, Richard ^{[12
,13
]}

Hall, Geoff D. ^{[14
]}

Clamp, Andrew ^{[15
]}

Gourley, Charlie ^{[16
]}

Hall, Marcia ^{[17
]}

Fotopoulou, Christina ^{[18
]}

Gabra, Hani ^{[18
,19
]}

Paul, James ^{[4
]}

Supernat, Anna ^{[1
]}

Millan, David ^{[20
]}

Hoyle, Aoisha ^{[20
]}

Bryson, Gareth ^{[20
]}

Nourse, Craig ^{[2
]}

Mincarelli, Laura ^{[2
]}

Sanchez, Luis Navarro ^{[2
]}

Ylstra, Bauke ^{[3
]}

Jimenez-Linan, Mercedes ^{[21
,22
]}

Moore, Luiza ^{[21
,22
]}

Hofmann, Oliver ^{[2
,23
]}

Markowetz, Florian ^{[1
]}

McNeish, Iain A. ^{[2
,5
,18
]}

Brenton, James D. ^{[1
,21
,22
,24
]}

机构：

[1] Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England

[2] Univ Glasgow, Inst Canc Sci, Glasgow G61 1QH, Lanark, Scotland

[3] Vrije Univ Amsterdam Med Ctr, NL-1007 MB Amsterdam, Netherlands

[4] Univ Glasgow, Inst Canc Sci, Canc Res UK Clin Trials Unit, Glasgow G12 0YN, Lanark, Scotland

[5] Beatson West Scotland Canc Ctr, Glasgow G12 0YN, Lanark, Scotland

[6] Queen Mary Univ London, Barts Canc Inst, London EC1M 6BQ, England

[7] Univ Coll London Hosp, London WC1E 6BD, England

[8] Barts Hlth NHS Trust, London E1 1BB, England

[9] Guys Hosp, London SE1 9RT, England

[10] Bristol Canc Inst, Bristol BS2 8ED, Avon, England

[11] City Hosp, Birmingham B18 7QH, W Midlands, England

[12] Univ Manchester, Fac Biol Med & Hlth, Div Canc Sci, Manchester, Lancs, England

[13] St Marys Hosp, Manchester, Lancs, England

[14] Manchester Acad Hlth Sci Ctr, Dept Obstet & Gynaecol, Manchester, Lancs, England

[15] Cent Manchester NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, St Marys Hosp, Manchester, Lancs, England

[16] Level 5,Oxford Rd, Manchester, Lancs, England

[17] St Jamess Inst Oncol, Leeds LS9 7TF, W Yorkshire, England

[18] Christie Hosp, Manchester M20 4BX, Lancs, England

[19] Univ Edinburgh, MRC IGMM, Nicola Murray Ctr Ovarian Canc Res, Edinburgh EH4 2XR, Midlothian, Scotland

[20] Mt Vernon Canc Ctr, Northwood HA6 2RN, Middx, England

[21] Imperial Coll, Div Canc, London W12 0NN, England

[22] Imperial Coll, Dept Surg & Canc, Ovarian Canc Act Res Ctr, London W12 0NN, England

[23] Imperial Coll, London W12 0NN, England

[24] AstraZeneca, IMED Biotech Unit, Early Clin Dev, Cambridge, England

来源：

CLINICAL CANCER RESEARCH | 2019年 / 25卷 / 22期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：64 / 64

页数：1

共 50 条

[41] Serous Endometrial Intraepithelial Carcinoma with High-Grade Serous Ovarian Carcinoma: A Synchronous Presentation
Yethadka, Ramya
Nagaraj, Ranjitha Vodigenahalli
INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 22 (01)
[42] Advances in serous tubal intraepithelial carcinoma: correlation with high grade serous carcinoma and ovarian carcinogenesis
Li, Hong-Xia
Lu, Zhao-Hui
Shen, Keng
Cheng, Wen-Jun
Malpica, Anais
Zhang, Jing
Wei, Jian-Jun
Zhang, Zhi-Hong
Liu, Jinsong
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (03): : 848 - 857
[43] Patterns of tumor evolution in high grade serous ovarian carcinoma
Verhaak, Roel G. W.
Chang, Kyle
Kim, Hoon
Carter, Scott L.
Schultz, Nikolaus
Zhao, Fengmei
Shen, Hui
Laird, Peter
Sinah, Rileen
Muzny, Donna
Reid, Jeff
Nu, Jiangong
Drummond, Jennifer
Getz, Gad
Levine, Douglas A.
Wheeler, David A.
CANCER RESEARCH, 2012, 72
[44] Personalising Treatment for High-Grade Serous Ovarian Carcinoma
Cojocaru, E.
Parkinson, C. A.
Brenton, J. D.
CLINICAL ONCOLOGY, 2018, 30 (08) : 515 - 524
[45] NF1 copy number loss is associated with poorer survival in the homologous recombination deficient subpopulation of high-grade serous ovarian carcinoma
Stillie, Lorna J.
Ewing, Ailith
Meynert, Alison
Thomson, John P.
Churchman, Michael
Herrington, C. Simon
Roxburgh, Patricia
Inman, Gareth J.
Hollis, Robert L.
Semple, Colin A.
Gourley, Charlie
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A391 - A391
[46] Molecular Management of High-Grade Serous Ovarian Carcinoma
Punzon-Jimenez, Paula
Lago, Victor
Domingo, Santiago
Simon, Carlos
Mas, Aymara
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
[47] Molecular Analysis of High-Grade Serous Ovarian Carcinoma Exhibiting Low-Grade Serous Carcinoma and Serous Borderline Tumor
Kanno, Kosuke
Nakayama, Kentaro
Razia, Sultana
Islam, Sohel Hasibul
Farzana, Zahan Umme
Sonia, Shahataj Begum
Sasamori, Hiroki
Yamashita, Hitomi
Ishibashi, Tomoka
Ishikawa, Masako
Imamura, Kayo
Ishikawa, Noriyoshi
Kyo, Satoru
CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (09) : 9376 - 9385
[48] Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma
Santillan, A.
Kim, Y. W.
Zahurak, M. L.
Gardner, G. J.
Giuntoli, R. L., II
Shih, I. M.
Bristow, R. E.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (03) : 601 - 606
[49] Histotype-specific copy-number alterations in ovarian cancer
Ruby YunJu Huang
Geng Bo Chen
Noriomi Matsumura
Hung-Cheng Lai
Seiichi Mori
Jingjing Li
Meng Kang Wong
Ikuo Konishi
Jean-Paul Thiery
Liang Goh
BMC Medical Genomics, 5
[50] Epigenomic signatures of acquired platinum resistance in high grade serous ovarian cancer
Fang, Fang
Cardenas, Horacio
Jiang, Guanglong
Perkins, Susan M.
Zhang, Chi
Keer, Harold
Liu, Yunlong
Matei, Daniela
Nephew, Kenneth
CANCER RESEARCH, 2018, 78 (13)

← 1 2 3 4 5 →